Overview

Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC)

Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine safety of Stromal Vascular Fraction (SVF) for the treatment of enterocutaneous fistula.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Instituto de Investigación Hospital Universitario La Paz